BitcoinWorld AI Drug Discovery Pioneer Converge Bio Secures Staggering $25M to Revolutionize Pharmaceutical R&D In a significant move that underscores the accelerating fusion of artificial intelligence and life sciences, Boston- and Tel Aviv-based startup Converge Bio announced on October 13, 2025, that it has secured a substantial $25 million Series A funding round. This investment, …










